Hisamitsu Pharmaceutical Co., Inc.
HTSUY · OTC
8/31/2025 | 5/31/2025 | 2/28/2025 | 11/30/2024 | |
|---|---|---|---|---|
| Market Cap | – | $1,970,489 | $1,977,208 | $2,068,425 |
| - Cash | $411,687 | $721,487 | $759,932 | $682,571 |
| + Debt | $9,746 | $18,337 | $25,588 | $19,496 |
| Enterprise Value | – | $1,267,339 | $1,242,863 | $1,405,350 |
| Revenue | $275,091 | $237,503 | $290,574 | $240,373 |
| % Growth | 15.8% | -18.3% | 20.9% | – |
| Gross Profit | $169,420 | $145,838 | $161,075 | $147,587 |
| % Margin | 61.6% | 61.4% | 55.4% | 61.4% |
| EBITDA | $55,041 | $37,580 | $72,162 | $52,524 |
| % Margin | 20% | 15.8% | 24.8% | 21.9% |
| Net Income | $30,447 | $17,567 | $52,579 | $30,633 |
| % Margin | 11.1% | 7.4% | 18.1% | 12.7% |
| EPS Diluted | 0.11 | 0.06 | 0.18 | 0.1 |
| % Growth | 83% | -66.6% | 80% | – |
| Operating Cash Flow | – | – | – | – |
| Capital Expenditures | – | – | – | – |
| Free Cash Flow | – | – | – | – |